ArticleDiscover oncology2025

Multi-omics analysis identifies DLX4 as a novel biomarker for diagnosis, prognosis, and immune infiltration: from pan-cancer to renal cancer.

Zengshun Kou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.